4//SEC Filing
Pla Frederic 4
Accession 0001209191-19-056634
CIK 0001131324other
Filed
Nov 13, 7:00 PM ET
Accepted
Nov 14, 9:40 PM ET
Size
27.3 KB
Accession
0001209191-19-056634
Insider Transaction Report
Form 4
Pla Frederic
Chief Bus & Prod Dev Officer
Transactions
- Disposition to Issuer
Employee Stock Option (right to buy) Holding
2019-11-08−28,570→ 0 totalExercise: $72.52Exp: 2029-01-29→ Common Stock (28,570 underlying) - Disposition to Issuer
Common Stock
2019-11-08−18,510→ 13,381 total - Disposition to Issuer
Employee Stock Option (right to buy) Holding
2019-11-08−5,142→ 0 totalExercise: $27.00Exp: 2026-02-16→ Common Stock (5,142 underlying) - Disposition to Issuer
Employee Stock Option (right to buy) Holding
2019-11-08−24,864→ 17,538 totalExercise: $27.48Exp: 2027-01-31→ Common Stock (24,864 underlying) - Disposition to Issuer
Common Stock
2019-11-08−13,381→ 0 total - Disposition to Issuer
Employee Stock Option (right to buy)
2019-11-08−77,167→ 0 totalExercise: $31.98Exp: 2025-01-01→ Common Stock (77,167 underlying) - Disposition to Issuer
Employee Stock Option (right to buy) Holding
2019-11-08−12,625→ 5,142 totalExercise: $27.00Exp: 2026-02-16→ Common Stock (12,625 underlying) - Disposition to Issuer
Employee Stock Option (right to buy) Holding
2019-11-08−17,538→ 0 totalExercise: $27.48Exp: 2027-01-31→ Common Stock (17,538 underlying) - Disposition to Issuer
Employee Stock Option (right to buy) Holding
2019-11-08−37,986→ 0 totalExercise: $33.21Exp: 2028-01-31→ Common Stock (37,986 underlying) - Disposition to Issuer
Employee Stock Option (right to buy) Holding
2019-11-08−29,544→ 37,986 totalExercise: $33.21Exp: 2028-01-31→ Common Stock (29,544 underlying)
Footnotes (10)
- [F1]Disposed of in connection with the acquisition of Issuer (the "Merger") by Exact Sciences Corporation ("Exact Sciences") pursuant to the Agreement and Plan of Merger, dated July 28, 2019 (the "Merger Agreement"), among Exact Sciences,Spring Acquisition Corp., and Issuer, whereby such shares of Issuer common stock were cancelled and converted into the right to receive a cash payment of $509,065 and 8,337 shares of Exact Sciences common stock, having a market value of $79.95 per share based on the closing price of Exact Sciences common stock on November 7, 2019.
- [F10]Disposed of in connection with the Merger, whereby such Issuer stock option was assumed by Exact Sciences and converted into a corresponding award for an option to purchase 21,865 shares of Exact Sciences common stock with an exercise price of $94.76 per share.
- [F2]Disposed of in connection with the Merger, whereby such Issuer restricted stock unit ("RSU") was assumed by Exact Sciences and converted into a corresponding award for 10,240 RSUs of Exact Sciences common stock, having a market value of $79.95 per share based on the closing price of Exact Sciences common stock on November 7, 2019.
- [F3]Disposed of in connection with the Merger, whereby such Issuer stock option was cancelled in exchange for a cash payment of $1,106,704, less applicable tax withholdings, and 18,127 shares of Exact Sciences common stock, having a market value of $79.95 per share based on the closing price of Exact Sciences common stock on November 7, 2019.
- [F4]Disposed of in connection with the Merger, whereby such Issuer stock option was cancelled in exchange for a cash payment of $206,933, less applicable tax withholdings, and 3,389 shares of Exact Sciences common stock, having a market value of $79.95 per share based on the closing price of Exact Sciences common stock on November 7, 2019.
- [F5]Disposed of in connection with the Merger, whereby such Issuer stock option was assumed by Exact Sciences and converted into a corresponding award for an option to purchase 3,935 shares of Exact Sciences common stock with an exercise price of $35.28 per share.
- [F6]Disposed of in connection with the Merger, whereby such Issuer stock option was cancelled in exchange for a cash payment of $402,628, less applicable tax withholdings, and 6,594 shares of Exact Sciences common stock, having a market value of $79.95 per share based on the closing price of Exact Sciences common stock on November 7, 2019.
- [F7]Disposed of in connection with the Merger, whereby such Issuer stock option was assumed by Exact Sciences and converted into a corresponding award for an option to purchase 13,422 shares of Exact Sciences common stock with an exercise price of $35.91 per share.
- [F8]Disposed of in connection with the Merger, whereby such Issuer stock option was cancelled in exchange for a cash payment of $408,759, less applicable tax withholdings, and 6,695 shares of Exact Sciences common stock, having a market value of $79.95 per share based on the closing price of Exact Sciences common stock on November 7, 2019.
- [F9]Disposed of in connection with the Merger, whereby such Issuer stock option was assumed by Exact Sciences and converted into a corresponding award for an option to purchase 29,071 shares of Exact Sciences common stock with an exercise price of $43.40 per share.
Documents
Issuer
GENOMIC HEALTH INC
CIK 0001131324
Entity typeother
Related Parties
1- filerCIK 0001649167
Filing Metadata
- Form type
- 4
- Filed
- Nov 13, 7:00 PM ET
- Accepted
- Nov 14, 9:40 PM ET
- Size
- 27.3 KB